Sally Crawford

Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA.

CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA

Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.

Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA.

Universal American Corp. provides health insurance and managed care products and services to the senior population. The company's health insurance products for the senior market include Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. It also provides administrative services for senior market insurance and non-insurance programs to affiliated and unaffiliated insurance companies and prescription benefit management services. The company was founded on August 31, 1981 and is headquartered in Rye Brook, NY.

CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA

Universal American Corp. provides health insurance and managed care products and services to the senior population. The company's health insurance products for the senior market include Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. It also provides administrative services for senior market insurance and non-insurance programs to affiliated and unaffiliated insurance companies and prescription benefit management services. The company was founded on August 31, 1981 and is headquartered in Rye Brook, NY.

Universal American Corp. provides health insurance and managed care products and services to the senior population. The company's health insurance products for the senior market include Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. It also provides administrative services for senior market insurance and non-insurance programs to affiliated and unaffiliated insurance companies and prescription benefit management services. The company was founded on August 31, 1981 and is headquartered in Rye Brook, NY.

Chittenden Corp. operates as a commercial bank. The company provides various financial products and services in the United States. The bank's loan portfolio comprises commercial loans, commercial and industrial, municipal, multifamily, commercial real estate, and construction. The company was founded in 1904 and is located in Burlington, VT.

Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.

CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA

Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA.

Universal American Corp. provides health insurance and managed care products and services to the senior population. The company's health insurance products for the senior market include Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. It also provides administrative services for senior market insurance and non-insurance programs to affiliated and unaffiliated insurance companies and prescription benefit management services. The company was founded on August 31, 1981 and is headquartered in Rye Brook, NY.

Universal American Corp. provides health insurance and managed care products and services to the senior population. The company's health insurance products for the senior market include Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. It also provides administrative services for senior market insurance and non-insurance programs to affiliated and unaffiliated insurance companies and prescription benefit management services. The company was founded on August 31, 1981 and is headquartered in Rye Brook, NY.

Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.

CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA

Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA.

Universal American Corp. provides health insurance and managed care products and services to the senior population. The company's health insurance products for the senior market include Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. It also provides administrative services for senior market insurance and non-insurance programs to affiliated and unaffiliated insurance companies and prescription benefit management services. The company was founded on August 31, 1981 and is headquartered in Rye Brook, NY.

Universal American Corp. provides health insurance and managed care products and services to the senior population. The company's health insurance products for the senior market include Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. It also provides administrative services for senior market insurance and non-insurance programs to affiliated and unaffiliated insurance companies and prescription benefit management services. The company was founded on August 31, 1981 and is headquartered in Rye Brook, NY.

Universal American Corp. provides health insurance and managed care products and services to the senior population. The company's health insurance products for the senior market include Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. It also provides administrative services for senior market insurance and non-insurance programs to affiliated and unaffiliated insurance companies and prescription benefit management services. The company was founded on August 31, 1981 and is headquartered in Rye Brook, NY.

Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.

CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA

Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.

Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.

CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA

Universal American Corp. provides health insurance and managed care products and services to the senior population. The company's health insurance products for the senior market include Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. It also provides administrative services for senior market insurance and non-insurance programs to affiliated and unaffiliated insurance companies and prescription benefit management services. The company was founded on August 31, 1981 and is headquartered in Rye Brook, NY.

Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA.

Universal American Corp. provides health insurance and managed care products and services to the senior population. The company's health insurance products for the senior market include Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. It also provides administrative services for senior market insurance and non-insurance programs to affiliated and unaffiliated insurance companies and prescription benefit management services. The company was founded on August 31, 1981 and is headquartered in Rye Brook, NY.

Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.

CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA

Universal American Corp. provides health insurance and managed care products and services to the senior population. The company's health insurance products for the senior market include Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. It also provides administrative services for senior market insurance and non-insurance programs to affiliated and unaffiliated insurance companies and prescription benefit management services. The company was founded on August 31, 1981 and is headquartered in Rye Brook, NY.

Universal American Corp. provides health insurance and managed care products and services to the senior population. The company's health insurance products for the senior market include Medicare Advantage, insured stand-alone prescription drug benefit plans pursuant to Medicare Part D, and Medicare supplement. It also provides administrative services for senior market insurance and non-insurance programs to affiliated and unaffiliated insurance companies and prescription benefit management services. The company was founded on August 31, 1981 and is headquartered in Rye Brook, NY.

Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA.

Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA.